Fear of Cancer Recurrence in an Era of Personalized Medicine

J Clin Oncol. 2017 Oct 10;35(29):3275-3278. doi: 10.1200/JCO.2017.72.8212. Epub 2017 Jul 19.

Authors

Belinda Thewes¹, Olga Husson¹, Hanneke Poort¹, Jose A E Custers¹, Phyllis N Butow¹, Sue-Anne McLachlan¹, Judith B Prins¹

Affiliation

¹ Belinda Thewes, Olga Husson, Hanneke Poort, Jose A.E. Custers, Radboud University Medical Center, Nijmegen, the Netherlands; Phyllis N. Butow, The University of Sydney, Sydney, New South Wales, Australia; Sue-Anne McLachlan, St Vincent's Hospital, Melbourne, and The University of Melbourne, Parkville, Victoria, Australia; and Judith B. Prins, Radboud University Medical Center, Nijmegen, the Netherlands.

PMID: 28723231
DOI: 10.1200/JCO.2017.72.8212

No abstract available

MeSH terms

Biomarkers, Tumor / genetics
Cancer Survivors / psychology*
Disease Progression
Fear*
Genetic Predisposition to Disease
Health Knowledge, Attitudes, Practice*
Humans
Molecular Targeted Therapy / adverse effects
Molecular Targeted Therapy / methods*
Molecular Targeted Therapy / mortality
Neoplasm Metastasis
Neoplasm Recurrence, Local*
Neoplasms / genetics
Neoplasms / mortality
Neoplasms / psychology
Neoplasms / therapy*
Phenotype
Precision Medicine*
Quality of Life
Time Factors
Treatment Outcome

Substances

Biomarkers, Tumor